This result was validated by gene enrichment analysis (GSEA) that showed enrichment of TGF-β signaling in the NR2F1 high group consistently in the three independent large primary breast cancer cohorts (TCGA, METABRIC, and GSE96058; Figure 1D). This evidence concerns the gene NR2F1 and breast carcinoma.